Inactive Instrument

News Intellego Technologies AB

Equities

INT

SE0016075063

Biotechnology & Medical Research

All News

04-14	Intellego admits 2023 sales figures are also inaccurate - Di	FW
04-08	Notice of extraordinary general meeting and first control meeting of Intellego Technologies AB (publ)	AQ
03-24	Indictment of former Intellego CEO postponed until July	FW
03-13	Board member departs Intellego - DI	FW
03-11	Mangold: Intellego shares trading at 9 kronor in grey market - Di	FW
03-10	Intellego shares trading at 1 SEK in grey market - EFN	FW
03-09	Intellego Technologies AB(OM:INT) dropped from S&P Global BMI Index	CI
03-04	Intellego to Be Delisted from Nasdaq First North (update)	FW
03-04	Decision on delisting from the Nasdaq First North Growth Market trading platform will be executed on 4 March 2026	AQ
03-04	Intellego Technologies to be delisted from Nasdaq Stockholm	RE
03-04	Intellego to Be Delisted from Nasdaq First North	FW
03-04	The Disciplinary Committee of Nasdaq Stockholm has decided to delist the shares in Intellego Technologies AB (publ) from Nasdaq First North Growth Market	AQ
03-02	Suspicions Against Möllerström Dropped in Intellego Investigation - Afv	FW
02-26	Board of Intellego Technologies resolves on staff cuts	RE
02-26	Intellego Announces Layoffs for Six Employees	FW
02-26	The board of directors of Intellego Technologies AB (publ) resolves on staff cuts	AQ
02-26	Intellego Technologies AB Resolves to Reduce the Permanent Workforce in Order to Strengthen the Company's Financial Position	CI
02-24	Intellego Technologies ousts CEO Jacob Laurin	RE
02-23	Intellego Technologies AB Announces Board Appointments	CI
02-23	Intellego's Newly Appointed Board Dismisses CEO Jacob Laurin	FW
02-23	The board of directors of Intellego Technologies AB (publ) dismisses the CEO	AQ
02-23	Intellego Technologies AB Announces Dismissal of CEO Jacob Laurin, Effective May 23, 2026	CI
02-23	Bulletin from the extraordinary general meeting of Intellego Technologies AB (publ)	AQ
02-20	Intellego Technologies AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
02-20	Intellego Reports Increased Loss	FW